- University Of Utah Hospital
About Dr. Robert H Andtbacka MD
Dr. Robert H Andtbacka has 3 locations
Dr. Robert H Andtbacka has the following 3 SPECIALTIES
Dr. Robert H Andtbacka has the following 3 expertise
- Gastrointestinal Tract Cancer (Gastrointestinal Stromal Tumors)
- Skin Cancer
Castle Connolly Regional Top Doctors (1)
Castle Connolly is America's trusted source for the identification of Top Doctors. Their physician-led research team reviews and screens the credentials of tens of thousands of physicians who are nominated by their peers annually, via a nationwide online process, before selecting those physicians who are regionally or nationally among the very best in their medical specialties. Castle Connolly believes strongly that Top Doctors Make a Difference.
Compassionate Doctor Recognition (2011, 2012, 2014)
Compassionate Doctor certification is granted to physicians who treat their patients with the utmost kindness. The honor is granted based on a physician's overall and bedside manner scores.
Patients' Choice Award (2011, 2012, 2014, 2015)
Patients' Choice recognition reflects the difference a particular physician has made in the lives of his/her patients. The honor is bestowed to physicians who have received near perfect scores, as voted by patients.
On-Time Doctor Award (2014, 2015)
Vitals On-Time + Promptness Award recognizes doctors with consistent high ratings for timeliness of appointments. The honor is granted based on a physician's overall and promptness scores.
24 Years Experience
Graduated in 1997
Dr. Robert H Andtbacka Accepts the Following Insurance
More about Dr. Robert H Andtbacka
Robert Andtbacka, MD, CM, is an assistant professor in the Division of Surgical Oncology, Department of Surgery at the University of Utah School of Medicine and a surgeon and investigator with Intermountain Healthcare and Huntsman Cancer Institute. He is a member of the Imaging, Diagnostics, and Therapeutics Program. He specializes in surgery for melanoma, soft tissue sarcomas, and cancers of the gastrointestinal tract. His research interests include novel techniques to identify how melanoma spreads through the lymph and vascular systems; resistance to targeted therapies in soft tissue sarcomas, including gastrointestinal stromal tumors; and novel therapeutics for solid tumors. In addition, he participates in multi-center clinical trials designed to improve diagnosis and treatments for cancer patients. Andtbacka received his medical degree from McGill University in Montreal, Canada, where he also completed a residency in general surgery. Before joining the University of Utah, he completed a three-year fellowship in surgical oncology at the University of Texas M.D. Anderson Cancer Center.